Top Markets
Coin of the day
GENinCode plc GENinCode plc

GENinCode plc

GENI
Classificação em ações #41228
GENinCode Plc specializes in the creation and commercialization of advanced... GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Preço da ação
$0.01206398
Valor de mercado
$33.74K
Variação (1 dia)
-1.49%
Variação (1 ano)
-40.77%
País
GB
Negociar GENinCode plc (GENI)

Categoria

Histórico de desdobramentos de ações de GENinCode plc (GENI)
As ações GENinCode plc (símbolo: GENI) passaram por um total de 0 desdobramentos.
O desdobramento mais recente ocorreu em Aug 13, 2026.
Uma ação GENI comprada antes de Aug 13, 2026 equivaleria hoje a 0 ações GENI.
Lista de desdobramentos de ações
Ano Desdobramento Multiplicador Multiplicador cumulativo
Não há dados suficientes para as datas fornecidas.
Desdobramentos de ações de empresas semelhantes ou concorrentes
Empresa Número de desdobramentos de ações Multiplicador cumulativo País
8 x34
US
7 x47
US
0 -
CN
4 x15
US
0 -
US